| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Growth Officer | Chief Commercial Officer
1 company
Shah Pritesh is a Chief Growth Officer at NovoCure Ltd. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2021 | NVCR Novocure Ltd | Chief Commercial Officer | Sell | 657 | $138.57 | $91,040.92 | -0.2% | -34.1% | -43.2% | |
| Aug 4, 2021 | NVCR Novocure Ltd | Chief Commercial Officer | Sell | 2,063 | $148.71 | $306,788.73 | -2.7% | -29.6% | -51.1% | |
| Aug 3, 2021 | NVCR Novocure Ltd | Chief Commercial Officer | Sell | 1,654 | $149.43 | $247,157.22 | -2.1% | -27.6% | -51.2% | |
| Jun 10, 2021 | NVCR Novocure Ltd | Chief Commercial Officer | Sell | 23,540 | $215.00 | $5,061,100.00 | -23.2% | -37.5% | -68.1% | |
| May 5, 2021 | NVCR Novocure Ltd | Chief Commercial Officer | Sell | 1,290 | $199.67 | $257,574.30 | -1.3% | -26.1% | -60.2% | |
| May 4, 2021 | NVCR Novocure Ltd | Chief Commercial Officer | Sale+OE | 1,043 | $200.86 | $209,492.81 | -1.0% | -23.6% | -58.4% | |
| Mar 9, 2021 | NVCR Novocure Ltd | Chief Commercial Officer | Sell | 6,151 | $130.97 | $805,588.52 | -2.9% | - | - | |
| Mar 5, 2021 | NVCR Novocure Ltd | Chief Commercial Officer | Sale+OE | 4,550 | $131.53 | $598,461.50 | -4.1% | - | - | |
| Mar 4, 2021 | NVCR Novocure Ltd | Chief Commercial Officer | Sell | 4,832 | $143.50 | $693,414.25 | -2.4% | - | - | |
| Mar 2, 2021 | NVCR Novocure Ltd | Chief Commercial Officer | Sell | 912 | $152.05 | $138,672.34 | -1.0% | - | - |